Breaking News

ResearchDx Completes Relocation

By Gil Roth | July 22, 2013

Celebrates move with open house event

ResearchDx has completed the purchase, build-out and relocation of its 30,000-sq.-ft. facility in Irvine, CA. The custom-designed facility will support the company's expansion of in vitro diagnostic (IVD) development services to the pharma, biotechnology, diagnostic development and clinical laboratory industries.

To celebrate this event, ResearchDx will be holding an open house on Tuesday, July 23 from 1-7 p.m. The event is open to anyone with a professional or personal interest in diagnostics and diagnostic development. Laboratory tours and technology presentations will be conducted throughout the afternoon, and food and beverages will be served. For more information regarding this event please contact Natalie McCan at nmccan@researchdx.com.

ResearchDx provides integrated, flexible services for the IVD development process, including initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, as well clinical research services and regulatory approval.

Related Compliance:

blog comments powered by Disqus
  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • What is Driving the Outsourcing Market?

    What is Driving the Outsourcing Market?

    Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences||January 29, 2015
    CRO industry generates healthy partnerships through co-development of drugs, diagnostics and demand for functional services.